MNKD : Analysis & Opinions

  1. Sanofi Gets Hosed on MannKind Deal (SNY, MNKD)

    November 11, 2016
    Sanofi will take a $100 million hit after settling a botched deal to market MannKind's Afrezza inhalable insulin.
  2. Can MannKind Compete Against Mylan's EpiPen? (MNKD)

    September 26, 2016
    MannKind’s plan to compete against Mylan's EpiPen may dissolve as the company is running short on cash
  3. MNKD: How MannKind's Stock Price Fell 28% in 6 Months

    September 16, 2016
    MannKind's stock price declined nearly 30% in the past six months, as of August 2016. Many traders are betting that the company ...
  4. MannKind Stock: 3 Things to Watch (MNKD)

    September 13, 2016
    Investors in Mannkind should monitor expense growth, liquidity ratios and book value as the company is threatened by bankruptcy ...
  5. The Top 5 Small-Cap Biotechnology Stocks for 2016

    December 14, 2015
    Discover the top five small-cap biotechnology stocks for 2016, with a summary, growth outlook and expected price target for ...
  6. 6 Stocks Poised For A Short Squeeze

    November 4, 2015
    SunGard's Astec Analytics looks into short-selling activity on a weekly basis. This week’s top pick from a securities lending ...
  7. Analysts Battle Over MannKind -- but Who's Right? (MNKD, SNY)

    July 1, 2015
    Source: YCharts. The past two months have brought about some very turbulent times for MannKind (NASDAQ: MNKD) shareholders. ...
  8. MannKind's 3 Can't-Miss Quotes at Goldman Sachs (MNKD)

    June 17, 2015
    MannKind Corp. (NASDAQ: MNKD) recently updated Wall Street investors of its progress at Goldman Sachs' annual global healthcare ...
  9. Is This Diabetes Stock a Better Bet Than MannKind? (MNKD, NVO)

    May 27, 2015
    MannKind's (NASDAQ: MNKD) inhaled insulin, Afrezza, is incredibly intriguing, but Novo Nordisk's (NYSE: NVO) long-standing ...
  10. 5 Things MannKind's Management Wants You to Know (MNKD, SNY)

    May 15, 2015
    MannKind (NASDAQ: MNKD) has always believed that it is on a mission to revolutionize patient treatment. While that might ...
  11. Is This Why MannKind Investors Are Bullish? (MNKD)

    March 18, 2015
    Although MannKind (NASDAQ: MNKD) stumbled along the way toward the launch of its inhaled-insulin drug, Afrezza, many believe ...
  12. Capitalize On This Small Stock's Insider Moves For 40% Upside

    October 25, 2013
    I couldn't believe my good fortune. It was my first day investing with real money at a proprietary trading firm. I had just ...
  13. Market Wrap for Wednesday, August 14: U.S. Stocks Fall Mid-Week; ...

    August 14, 2013
    The U.S. stock market fell for most of Wednesday's trading session, finishing near its worst levels of the day. The ...
  14. Investing For The Global Diabetes Epidemic

    May 31, 2013
    Sadly, diabetes is quickly becoming a global epidemic. Within these grim statistics, investors can find opportunities with ...
  15. 3 Stocks Ripe for Upside Reversals

    July 23, 2011
    Sentiment seems to be turning more favorable toward these three stocks, and given new insider buying, shares may be ready ...
  16. Novo Nordisk Still One Of The Best Around

    May 3, 2011
    Novo Nordisk is one of the best pharmaceutical companies in the world - and it's priced accordingly.